NIH Admits Fauci Lied About Gain-Of-Function Funding To Wuhan Lab

NIH Admits Fauci Lied About Gain-Of-Function Funding To Wuhan Lab

by Joe Kinsey 6 days

In a letter released Wednesday, a top National Institute of Health official admitted taxpayers help fund gain-of-function research on bat coronaviruses and noted that EcoHealth Alliance, which helped funnel money to the Wuhan lab “failed to report” findings “required by the terms of the grant.”

Dr. Richard Ebright, a molecular biologist at Rutgers University, who was critical of Dr. Anthony Fauci’s gain-of-function testimony in front of the Senate back in May where Fauci claimed, during an exchange with Sen. Rand Paul that “the NIH [National Institutes of Health] has not ever and does not now fund gain of function research in the Wuhan Institute of Virology [WIV],” writes that Wednesday’s letter “corrects untruthful assertions” from Fauci and former NIH director Dr. Francis Collins.

Ebright tweeted Wednesday that the letter sent by Lawrence A. Tabak of the NIH to Republican Rep. James Comer shows that “untruthful assertions by NIH Director Collins and NIAID Director Fauci that NIH had not funded gain-of-function research in Wuhan.”

A vindicated Rand Paul wasted no time correcting the record.

“HHS Deputy admits Fauci’s NIH-funded gain-of-function research in Wuhan but says it was ‘an unexpected result,’” Sen. Paul tweeted Thursday morning. “If the experiment combines unknown viruses and tests their ability to infect and damage humanized cells, of course, the result is ‘unknown’ before the experiment.

“But it is not ‘unexpected’ that the virus gains in the function it is simply ‘unknown.’

“So, if this type of experiment created a virus that had 50% mortality (like MERS which they have experimented with in Wuhan), that result would be ‘unknown’ before the experiment but not ‘unexpected.’”

Here’s what Fauci told Sen. Paul in May 2021:

“The NIH has not ever and does not now fund gain-of-function in the Wuhan Institute. We have not funded gain-of-function on this…I will repeat again, the NIH and the NIAID categorically have not funded gain-of-function research.”

has 5 days to submit to NIH “unpublished data from the experiments and work conducted under this award.” Via @cathymcmorris NIH Letter
EcoHealth Alliance Year Five progress report
NIH genetic analysis report

— Catherine Herridge (@CBS_Herridge) October 20, 2021

October 20, 2021

The Honorable Cathy McMorris Rodgers

Ranking Member, Committee on Energy and Commerce

U.S. House of Representatives Washington, D.C. 20515

Dear Chair McMorris Rodgers:

Thank you for your continued interest in the work of the National Institutes of Health (NIH). I am writing today to provide additional information and documents regarding NIH’s grant to EcoHealth Alliance, Inc.

It is important to state at the outset that published genomic data demonstrate that the bat

coronaviruses studied under the NIH grant to EcoHealth Alliance, Inc. and sub-award to the

Wuhan Institute of Virology (WIV) is not and could not have become SARS-CoV-2. Both the progress report and the analysis attached here again confirm that conclusion, as the sequences of the viruses are genetically very distant.

The fifth and final progress report for Grant R01AI110964, awarded to EcoHealth Alliance, Inc. is attached with redactions only for personally identifiable information. This progress report was submitted to NIH in August 2021 in response to NIH’s compliance enforcement efforts. It

includes data from a research project conducted during the 2018-19 grant period using bat coronavirus genome sequences already existing in nature.

The limited experiment described in the final progress report provided by EcoHealth Alliance was testing if spike proteins from naturally occurring bat coronaviruses circulating in China were capable of binding to the human ACE2 receptor in a mouse model. All other aspects of the mice, including the immune system, remained unchanged. In this limited experiment, laboratory mice infected with the SHC014 WIV1 bat coronavirus became sicker than those infected with the WIV1 bat coronavirus. As sometimes occurs in science, this was an unexpected result of the research, as opposed to something that the researchers set out to do. Regardless, the viruses

being studied under this grant were genetically very distant from SARS-CoV-2.

The research plan was reviewed by NIH in advance of funding, and NIH determined that it did not to fit the definition of research involving enhanced pathogens of pandemic potential (ePPP)

because these bat coronaviruses had not been shown to infect humans. As such, the research was not subject to departmental review under the HHS P3CO Framework. However, out of an

abundance of caution and as an additional layer of oversight, language was included in the terms and conditions of the grant award to EcoHealth that outlined criteria for a secondary review, such as a requirement that the grantee report immediately a one log increase in growth. These

The Honorable Cathy McMorris Rodgers

measures would prompt a secondary review to determine whether the research aims should be re-evaluated or new biosafety measures should be enacted.

EcoHealth failed to report this finding right away, as was required by the terms of the grant. EcoHealth is being notified that they have five days from today to submit to NIH any and all unpublished data from the experiments and work conducted under this award. Additional

compliance efforts continue.

The second document is a genetic analysis demonstrating that the naturally occurring bat

coronaviruses used in experiments under the NIH grant from 2014-2018 are decades removed

from SARS-CoV-2 evolutionarily. The analysis compares the sequence relationships between:

  • SARS-CoV-1, the cause of the SARS outbreak in 2003;
  • SARS-CoV-2, the cause of COVID-19 pandemic;
  • WIV-1, a naturally occurring bat coronavirus used in experiments funded by the NIH;
  • RaTG13, one of the closest bat coronavirus relatives to SARS-CoV-2 collected by the Wuhan Institute of Virology; and
  • BANAL-52, one of several bat coronaviruses recently identified from bats living in caves in Laos.

While it might appear that the similarity of RaTG13 and BANAL-52 bat coronaviruses to SARS-

CoV-2 is close because it overlaps by 96-97%, experts agree that even these viruses

are far too divergent to have been the progenitor of SARS-CoV-2. For comparison, today’s human genome is 96% similar to our closest ancestor, the chimpanzee. Humans and

chimpanzees are thought to have diverged approximately 6 million years ago.

The analysis attached confirms that the bat coronaviruses studied under the EcoHealth Alliance grant could not have been the source of SARS-CoV-2 and the COVID-19 pandemic.

If you or your staff have questions, NIH would be pleased to brief you on these documents.

Lawrence A. Tabak, D.D.S., Ph.D. Principal Deputy Director

The NIH received the relevant documents in 2018 and reviewed the documents in 2020 and again in 2021.

The NIH–specifically, Collins, Fauci, and Tabak–lied to Congress, lied to the press, and lied to the public. Knowingly. Willfully. Brazenly.

— Richard H. Ebright (@R_H_Ebright) October 20, 2021

The NIH finally admits they funded gain of function research on bat coronaviruses…Fauci lied.

Then they assert that it couldn’t have caused the pandemic because humans evolve at the same rate as viruses…

This is probably the dumbest comparison I’ve seen from a scientific org.

— James Todaro, MD (@JamesTodaroMD) October 21, 2021

Written by Joe Kinsey

I’m an Ohio guy, born in Dayton, who roots for Ohio State and can handle you guys destroying the Buckeyes, Urban Meyer and everything associated with Columbus.

Leave a Reply

HTML Snippets Powered By :